SC
TMO icon

Sculptor Capital’s Thermo Fisher Scientific TMO Stock Holding History

Sculptor Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-750,400
Closed -$97.4M – 451
2015
Q2 		$97.4M Buy
+750,400
New +$97.8M 0.28% 76
2014
Q4 		– Sell
-250,000
Closed -$30.4M – 828
2014
Q3 		$30.4M Sell
250,000
-226,500
-48% -$27.5M 0.09% 203
2014
Q2 		$56.2M Buy
476,500
+78,700
+20% +$9.26M 0.17% 143
2014
Q1 		$47.8M Sell
397,800
-32,400
-8% -$3.85M 0.16% 138
2013
Q4 		$47.9M Buy
430,200
+377,500
+716% +$37.5M 0.12% 208
2013
Q3 		$4.86M Sell
52,700
-95,500
-64% -$8.64M 0.01% 540
2013
Q2 		$12.5M Buy
+148,200
New +$12.3M 0.04% 393

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Sculptor Capital's TMO Position: Q2 2023 in Review

Sculptor Capital sold out of Thermo Fisher Scientific (TMO) in Q2 2023, closing a stake of 211,071 shares — an estimated $122M sold.

Sculptor Capital first reported a position in TMO in Q2 2013 and held it in 15 quarters. The position peaked at $610M in Q4 2013. 2,387 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

  • Sculptor Capital reported no remaining Thermo Fisher Scientific position as of Q2 2023 after selling out during the quarter.
  • Sculptor Capital sold 211,071 Thermo Fisher Scientific shares in Q2 2023, an estimated $122M.
  • Sculptor Capital first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 15 quarters.
  • Sculptor Capital's Thermo Fisher Scientific position peaked at $610M in Q4 2013.
  • 2,387 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on Sculptor Capital's 13F filing for Q2 2023, filed 14 Aug 2023.